KCLG Medical connects Phase I and II oncology sponsors with pre-qualified patients actively seeking trials — backed by GCP-compliant operations, an experienced CRA team, and a patient navigation platform built for oncology.
The enrolment bottleneck is real: the median time from first patient screened to first patient dosed in Phase I oncology is now over 5 months. The primary cause is not site availability — it's unqualified referrals, narrow biomarker windows, and patient navigation gaps. KCLG was built to close that gap.
Our patient navigation platform attracts active oncology patients and caregivers searching for trial options. Before a patient reaches a sponsor site, our navigators have confirmed diagnosis type, line of therapy, treatment status, and geographic availability — reducing screen failure rates from the first call.
KCLG is not a trial registry or a patient database. We are a GCP-certified CRO with hands-on Phase I–III execution experience — protocol review, site qualification, regulatory package preparation, monitoring, and study startup. We can operate as your CRO, your patient recruitment partner, or both.
We conduct structured CRA feasibility audits on community oncology sites — identifying staffing gaps, SOP deficiencies, and IRB readiness issues before sponsors waste time on site qualification visits. Sponsors working with KCLG get assessed sites, not blind referrals.
We review your protocol, eligibility criteria, and enrolment timeline. We assess fit with our patient platform and site network within 48 hours.
We deliver a written feasibility assessment: estimated patient volume, site recommendations, timeline, and a fixed-fee proposal scoped to your study.
Regulatory package prep, site qualification, IRB submission support, and delegation log setup — executed by our CRA team to GCP/ICH E6(R3) standard.
Patient pre-screening, site monitoring visits, query resolution, and enrolment reporting — with regular sponsor updates throughout the accrual period.
All services are scoped and fixed-fee. We work as a full CRO partner, a patient recruitment supplement to your existing CRO, or on individual service lines.
Protocol-specific patient matching from our navigation platform. Patients are pre-qualified against your key eligibility criteria before site referral.
Regulatory package preparation, site qualification, IRB submission coordination, and study startup project management.
Remote and on-site monitoring visits, query management, protocol deviation review, and enrolment reporting to ICH E6(R3) standard.
Independent remote audit of community oncology sites — staffing, SOPs, regulatory binder, and workflow capacity. Report delivered in 15 business days.
Custom patient demand analysis, site performance benchmarks, and enrolment velocity projections for your protocol's eligibility criteria.
Sponsored feature in our B2B oncology newsletter (1,400+ clinical ops subscribers) and featured protocol placement on our patient navigation platform.
All CRA staff certified to GCP/ICH E6(R3) standard
Operations aligned with FDA 21 CFR Parts 11, 50, 56, 312
Registered research organisation with active trial listings
HIPAA-aligned patient navigation with consent-based data handling
"Community oncology sites are where the patients are — but most CROs don't know how to qualify and activate them efficiently. KCLG's audit-first approach and pre-screened referral pipeline addresses exactly the bottleneck that delays our Phase II timelines."— Clinical Operations Director, Oncology Biotech (composite)
Send us your protocol synopsis and eligibility criteria. We will respond within one business day with a preliminary feasibility assessment and a call to discuss fit. No obligation, no RFP required to start the conversation.
Or email directly: keog@kclgmedical.com · Call: 312-225-3916